Compare
2 stocks, side by sideRelative performance · rebased to 100
GSKPFE
Pair ratio · GSK ÷ PFERelative value, rich or cheap vs their own history
The price ratio GSK ÷ PFE with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| GSKGSK plc | PFEPfizer | |
|---|---|---|
| Smart Score | 9/10 | 7/10 |
| Price | $51.89 | $24.04 |
| 1 month | +0.76% | -7.2% |
| 1 year | +39% | +7.0% |
| 5 year | +57% | -21% |
| P/E (TTM) | 17.8 | 18.2 |
| P/E vs sector | -43% | - |
| Market cap | $104.0B | $143.7B |
| Sector | Healthcare | Health Care |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.